2 High-Octane Cannabis Stocks to Buy in October for Aggressive Investors

Trulieve reported Q2 revenue of $271 million, down 10% year over year, but returned to adjusted EPS profitability of $0.11 versus a $0.04 loss; its shares are up more than 28% year to date. Innovative Industrial Properties posted $63.3 million in Q2 revenue and AFFO per share of $1.83, up 7%, while offering a dividend yield above 14%, though its roughly 104% AFFO payout ratio raises cut risk. Both companies have comparatively conservative balance sheets, but Trulieve faces cannabis-price margin pressure and regulatory uncertainty around Schedule III rescheduling, while IIPR remains exposed to tenant distress.

Analysis

IIPR is best viewed as a stressed-credit/real-estate recovery rather than a conventional high-yield REIT. The dividend yield is pricing a meaningful probability of a cut, and the critical variable is not headline AFFO growth but rent collection, tenant concentration, lease amendments, and the time required to redeploy impaired properties. A dividend reset could initially drive a 15-25% drawdown, but if it funds re-leasing or property repurchases rather than masks tenant distress, the equity could ultimately rerate from a distressed yield vehicle toward NAV.

For Trulieve, any reduction in federal tax friction has asymmetric earnings sensitivity because fixed operating infrastructure is already in place; the market should capitalize incremental cash flow well before a full statutory change is implemented. The near-term risk is that investors front-run regulatory optimism while state-level price compression continues to erode gross-profit dollars. The claimed exchange-listing and index-flow benefit should be independently verified through passive-fund ownership and reported trading volumes; mechanical buying is transitory unless it broadens the shareholder base and lowers the cost of capital.

The more non-obvious beneficiary of an improving regulatory backdrop is not necessarily the largest operator but the operators that can finance expansion without distressed equity issuance. GTBIF is likely the cleaner relative long versus more levered CURLF and CRLBF, while IIPR could benefit only if operator liquidity improves enough to stabilize its tenant base. Conversely, broad cannabis ETFs such as MSOS may dilute company-specific balance-sheet quality by retaining exposure to weaker issuers that face refinancing risk.

Consensus appears too focused on Schedule III as an immediate earnings switch. Regulatory implementation, IRS interpretation, and state-market oversupply can create a multi-quarter lag, so the durable catalyst is evidence of improving free cash flow and wholesale-price stabilization, not a policy headline. For IIPR, falsification is another material tenant default, collection deterioration, or a dividend declaration below the current run rate; for cannabis operators, it is declining EBITDA despite tax normalization expectations.

Key Decisions for Investors

• Avoid initiating IIPR solely for yield. Establish a small long only after the next earnings release confirms stable rent collection and no incremental major lease restructurings; target a 6-12 month recovery trade, with a hard reassessment on any dividend cut or AFFO coverage remaining below 1.0x.
• Prefer a 3-6 month quality pair: long GTBIF / short CURLF or CRLBF in equal dollar amounts. The thesis is that regulatory optimism and capital-market reopening should reward lower-leverage operators while penalizing issuers requiring refinancing or equity capital; exit if the net-debt/EBITDA gap narrows materially or state pricing improves broadly.
• Use MSOS only as a tactical policy catalyst vehicle, not a core long. Enter after independently confirmed federal implementation milestones rather than on rescheduling headlines; take profits into sharp headline-driven rallies because the ETF embeds weaker balance sheets and is vulnerable to financing dilution.
• Place an alert on Trulieve's reported gross-margin trend and operating cash flow over the next two quarters. A sustained margin floor combined with verifiable institutional ownership growth would justify a long; absent that evidence, the buyback is insufficient to offset structural pricing pressure.